PPP2CA — Protein Phosphatase 2 Catalytic Subunit Alpha

PPP2CA — Protein Phosphatase 2 Catalytic Subunit Alpha

Introduction

[PPP2CA](/genes/ppp2ca) encodes the alpha isoform of protein phosphatase 2A (PP2A), a major serine/threonine phosphatase that constitutes approximately 1% of total cellular proteins and accounts for the majority of phosphatase activity in the brain [@pp2a_neurodegeneration_2009]. PP2A is a heterotrimeric enzyme consisting of a catalytic subunit (C), a structural subunit (A), and one of many regulatory B subunits that determine substrate specificity, subcellular localization, and enzyme activity [@pp2a_structure_1999]. This gene is located on chromosome 5q31.1 and is essential for numerous cellular processes including cell cycle progression, signal transduction, protein synthesis, metabolism, and neuronal function. In the brain, PP2A plays critical roles in [tau](/proteins/tau) dephosphorylation, [apoptosis](/entities/apoptosis) regulation, synaptic plasticity, and neurodevelopment, making it a key player in neurodegenerative disease pathogenesis [@tau_hyperphosphorylation_2005].

PPP2CA — Protein Phosphatase 2 Catalytic Subunit Alpha

Introduction

[PPP2CA](/genes/ppp2ca) encodes the alpha isoform of protein phosphatase 2A (PP2A), a major serine/threonine phosphatase that constitutes approximately 1% of total cellular proteins and accounts for the majority of phosphatase activity in the brain [@pp2a_neurodegeneration_2009]. PP2A is a heterotrimeric enzyme consisting of a catalytic subunit (C), a structural subunit (A), and one of many regulatory B subunits that determine substrate specificity, subcellular localization, and enzyme activity [@pp2a_structure_1999]. This gene is located on chromosome 5q31.1 and is essential for numerous cellular processes including cell cycle progression, signal transduction, protein synthesis, metabolism, and neuronal function. In the brain, PP2A plays critical roles in [tau](/proteins/tau) dephosphorylation, [apoptosis](/entities/apoptosis) regulation, synaptic plasticity, and neurodevelopment, making it a key player in neurodegenerative disease pathogenesis [@tau_hyperphosphorylation_2005].

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Protein Phosphatase 2 Catalytic Subunit Alpha</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>PPP2CA</td></tr>
<tr><td><strong>Full Name</strong></td><td>Protein phosphatase 2 catalytic subunit alpha</td></tr>
<tr><td><strong>Chromosome</strong></td><td>5q31.1</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[5515](https://www.ncbi.nlm.nih.gov/gene/5515)</td></tr>
<tr><td><strong>OMIM</strong></td><td>176915</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000141837</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P67775](https://www.uniprot.org/uniprot/P67775)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Parkinson's Disease, FTLD, Cognitive Impairment</td></tr>
</table>
</div>

Molecular Structure and Function

Catalytic Subunit Structure

The PP2A catalytic subunit (PP2Ac) is a 36 kDa protein belonging to the phosphoprotein phosphatase (PPP) family. The crystal structure reveals a conserved catalytic core with active site residues essential for dephosphorylation of serine/threonine residues [@pp2a_structure_1999]. Two isoforms exist (alpha and beta), with PPP2CA being the predominant isoform in most tissues, including the brain. The catalytic subunit contains critical residues for metal ion binding (Mn²⁺ and Mg²⁺), which are required for phosphatase activity. Post-translational modifications including phosphorylation, methylation, and glycosylation regulate PP2Ac function [@b subunit_2011].

PP2A Holoenzyme Assembly

PP2A functions as a heterotrimeric complex consisting of:

• Catalytic subunit (C): PPP2CA or PPP2CB
• Scaffold/substrate binding subunit (A): PR65alpha (PPP2R1A) or PR65beta (PPP2R1B)
• Regulatory subunit (B): Determines substrate specificity and subcellular localization

Role in Neurodegenerative Diseases

Alzheimer's Disease

In Alzheimer's disease (AD), PP2A activity is significantly reduced in the brain, contributing to [tau hyperphosphorylation](/mechanisms/tau-pathology) and neurofibrillary tangle formation [@tau_hyperphosphorylation_2005]. PP2A is the primary phosphatase responsible for dephosphorylating tau at multiple sites that are hyperphosphorylated in AD, including Ser199, Thr205, Ser396, and Ser404. Reduced PP2A activity in AD brains correlates with:

• Increased tau phosphorylation at pathogenic sites
• Neurofibrillary tangle burden
• Cognitive decline severity

Parkinson's Disease

In Parkinson's disease (PD), PP2A plays a critical role in regulating [alpha-synuclein](/proteins/alpha-synuclein) phosphorylation at Ser129, which influences its aggregation, toxicity, and Lewy body formation [@alpha_syn_phosphorylation_2012]. PP2A dephosphorylates alpha-synuclein at Ser129, and reduced PP2A activity promotes pathogenic aggregation [@lewy_bodies_2013]. PP2A also:

• Regulates mitochondrial function and survival of dopaminergic neurons [@mitochondrial_2016]
• Controls autophagy through mTORC1 dephosphorylation [@autophagy_2016]
• Modulates neuroinflammation in PD models [@neuroinflammation_2015]

Frontotemporal Lobar Degeneration

PP2A dysfunction is also implicated in frontotemporal lobar degeneration (FTLD), where tau pathology is a key feature. Altered PP2A activity contributes to tau hyperphosphorylation and aggregation in FTLD subtypes [@ftld_2018].

Expression in the Brain

PPP2CA is ubiquitously expressed with high levels in brain tissue. Within the brain, PP2A is expressed in:

• Neurons: High expression in pyramidal neurons of the hippocampus and cortex
• Glial cells: Moderate expression in astrocytes and oligodendrocytes
• Synapses: Concentrated in pre- and post-synaptic compartments

Therapeutic Implications

PP2A Activators

PP2A activators are being developed as therapeutic agents for tauopathies including AD and PSP:

Biomarker Potential

PP2A activity in cerebrospinal fluid (CSF) shows promise as a biomarker for AD diagnosis and progression [@biomarker_2019]. Reduced CSF PP2A activity correlates with cognitive impairment and brain atrophy in AD patients.

Drug Development Challenges

• Blood-brain barrier penetration
• Selectivity for specific PP2A holoenzyme complexes
• Avoiding interference with essential cellular functions

Key Regulatory Mechanisms

Phosphorylation

PP2A catalytic subunit is phosphorylated at multiple sites:

• Tyr307 (inhibitory): Phosphorylated by src family kinases
• Thr304: Regulated by PRK/PDK1 pathway [@prk_2019]

Methylation

Leucine carboxyl methyltransferase 1 (LCMT1) methylates PP2A at Leu309, which is essential for holoenzyme assembly. This modification is reversible and regulated by PME-1 (phosphatase methylesterase-1).

Inhibition by Endogenous Toxins

Okadaic acid and microcystin are potent PP2A inhibitors produced by marine cyanobacteria and freshwater blooms, respectively. These toxins have been used extensively to study PP2A function in neurodegeneration models [@okadaic_2004].

Interactions with Other Neurodegeneration Pathways

Metal Ion Homeostasis

PP2A activity is sensitive to metal ion imbalance, which is relevant in neurodegeneration [@metal_2018]. Aluminum, iron, and copper exposure can inhibit PP2A, contributing to tau pathology.

Neuroinflammation

PP2A modulates neuroinflammation by regulating NF-κB and MAPK signaling pathways. Altered PP2A activity in microglia contributes to chronic neuroinflammation in AD and PD [@neuroinflammation_2015].

Autophagy

PP2A controls autophagy through dephosphorylation of mTORC1 substrates and ULK1 complex regulation. This connection is particularly relevant to protein aggregate clearance in neurodegenerative diseases [@autophagy_2016].

Disease Associations Table

| Disease | PP2A Dysfunction | Mechanism |
|---------|------------------|-----------|
| Alzheimer's Disease | ↓ Activity | Tau hyperphosphorylation, impaired dephosphorylation, methylation defects |
| Parkinson's Disease | ↓ Activity | Alpha-synuclein phosphorylation, mitochondrial dysfunction |
| FTLD | ↓ Activity | Tau hyperphosphorylation, aggregation |
| Cognitive Impairment | Variable | Synaptic plasticity deficits, methylation changes |
| PSP | ↓ Activity | Tau hyperphosphorylation at multiple sites |

Key Publications

Cross-Links

• [Protein Phosphatases](/proteins/protein-phosphatases)
• [Tau Pathology](/mechanisms/tau-pathology)
• [Alpha-Synuclein](/proteins/alpha-synuclein)
• [Apoptosis](/entities/apoptosis)
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
• [Neurodegeneration Mechanisms](/mechanisms/neurodegeneration)
• [Autophagy Pathways](/mechanisms/autophagy)
• [Neuroinflammation](/mechanisms/neuroinflammation)

See Also

• [Genes Index](/genes)
• [Proteins Index](/proteins)
• [Mechanisms Index](/mechanisms)
• [Diseases Index](/diseases)

External Links

• [NCBI Gene Database](https://www.ncbi.nlm.nih.gov/gene/5515)
• [UniProt - P67775](https://www.uniprot.org/uniprot/P67775)
• [Ensembl - ENSG00000141837](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000141837)
• [OMIM - 176915](https://www.omim.org/entry/176915)
• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving ppp2ca discovered through SciDEX knowledge graph analysis:

Pathway Diagram

The following diagram shows the key molecular relationships involving PPP2CA — Protein Phosphatase 2 Catalytic Subunit Alpha discovered through SciDEX knowledge graph analysis: